MoscucciMFoxKAACannonCP. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24(20):1815–1823.
2.
MehranRPocockSJNikolskyE. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55(23):2556–2566.
3.
MisumidaNOgunbayoOGKimSM. Higher risk of bleeding in Asians presenting with ST-elevation myocardial infarction: analysis of the National Inpatient Sample Database. Angiology. 2018;69(6):548–554.
4.
WangTYChenAYRoeMT. Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non–ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative. Am J Cardiol. 2007;100(3):391–396.
NdrepepaGFusaroMCasseseSGuerraESchunkertHKastratiA. Relation of body mass index to bleeding during percutaneous coronary interventions. Am J Cardiol. 2015;115(4):434–440.
7.
SaundersEOfiliE. Epidemiology of atherothrombotic disease and the effectiveness and risks of antiplatelet therapy. Cardiol Rev. 2008;16(2):82–88.
8.
SaitoSIsshikiTKimuraT. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. Circ J. 2014;78(7):1684–1692.
9.
ShimadaYJNakraNCFoxJTKaneiY. Relation of race (Asian, African-American, European-American, and Hispanic) to activated clotting time after weight-adjusted bolus of heparin during percutaneous coronary intervention. Am J Cardiol. 2010;105(5):629–632.
